The RANTES −28 g polymorphism is associated with primary sclerosing cholangitis
暂无分享,去创建一个
P. Rutgeerts | S. Vermeire | T. Roskams | F. Nevens | C. Verslype | L. Henckaerts | W. van Steenbergen | J. Fevery | P. Yap
[1] S. Vermeire,et al. CC‐Type chemokine receptor 5‐&Dgr;32 mutation protects against primary sclerosing cholangitis , 2006, Inflammatory bowel diseases.
[2] Paul Scheet,et al. A fast and flexible statistical model for large-scale population genotype data: applications to inferring missing genotypes and haplotypic phase. , 2006, American journal of human genetics.
[3] A. Satir,et al. Comparison of RANTES expression in Crohn’s disease and ulcerative colitis: an aid in the differential diagnosis? , 2006, Journal of Clinical Pathology.
[4] B. Müllhaupt,et al. Should we screen for colorectal cancer in liver transplantation? , 2006, Journal of hepatology.
[5] G. Gores,et al. "Will all liver transplantation patients eventually die from cancer?". , 2006, Journal of hepatology.
[6] S. Muhtaroğlu,et al. Treatment with Met-RANTES decreases bacterial translocation in experimental colitis. , 2006, American journal of surgery.
[7] Mark Daly,et al. Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..
[8] J. Goedert,et al. Modulating influence on HIV/AIDS by interacting RANTES gene variants , 2002, Proceedings of the National Academy of Sciences of the United States of America.